Publications in collaboration with researchers from Centro Nacional de Investigaciones Oncológicas (5)

2021

  1. Regulatory CDH4 Genetic Variants Associate With Risk to Develop Capecitabine-Induced Hand-Foot Syndrome

    Clinical Pharmacology and Therapeutics, Vol. 109, Núm. 2, pp. 462-470

2020

  1. Association between ABCB1 Genetic Variants and Persistent Chemotherapy-Induced Alopecia in Women with Breast Cancer

    JAMA Dermatology, Vol. 156, Núm. 9, pp. 987-991

2018

  1. Pharmacogenetic variants and response to neoadjuvant single-agent doxorubicin or docetaxel: A study in locally advanced breast cancer patients participating in the NCT00123929 phase 2 randomized trial

    Pharmacogenetics and Genomics, Vol. 28, Núm. 11, pp. 245-250

2015

  1. Standard versus continuous administration of capecitabine in metastatic breast cancer (GEICAM/2009-05): A randomized, noninferiority phase II trialwith a pharmacogenetic analysis

    Oncologist, Vol. 20, Núm. 2, pp. 111-112

2014

  1. Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: Investigation in the QUASAR2 study, systematic review, and meta-analysis

    Journal of Clinical Oncology, Vol. 32, Núm. 10, pp. 1031-1039